William N. Starling is General Partner of Synergy Life Science Partners, LP (www.synergylsp.com) and Chief Executive Officer of Synecor, LLC, (Synecor) a business generator of new Life Science companies based in Research Triangle Park (RTP), North Carolina, Santa Rosa, California, and Portola Valley, California. As CEO of Synecor, William is a cofounder of BaroSense, Inc., Bioerodible Vascular Solutions, Inc., (acquired by Guidant/Abbott in April 2004), InnerPulse, Inc. (formerly Interventional Rhythm Management, Inc.), TransEnterix, Inc., and Interventional Autonomics Corporation, the initial five companies founded and incubated by Synecor. William currently serves as Chairman of the Board of InnerPulse Inc., a RTP, NC - based cardiac rhythm management company, Chairman of the Board of Interventional Autonomics Corporation, and as a board member of TransEnterix, Inc., a RTP, NC - based less invasive GI Surgery company. William received his BS degree from the University of North Carolina at Chapel Hill and his MBA degree from the University of Southern California. He was subsequently part of the founding management team and Director of Marketing for Advanced Cardiovascular Systems, Inc. (acquired by Guidant/Abbott), and was a cofounder, Vice President and Board member of Ventritex, Inc. (acquired by St. Jude Medical). In 1992, William was a cofounder and Chairman of the Board of Directors and President/CEO of Cardiac Pathways Corporation (acquired by Boston Scientific Corporation), William serves as Chairman of the Board of Visitors at the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill and a Board of Visitor member of the Lineberger Comprehensive Cancer Center at UNC.